Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Expression of PSA-RP2, an alternatively spliced variant from the PSA gene, is increased in prostate cancer tissues but the protein is not secreted from prostate cancer cells.
Whitbread AK, Veveris-Lowe TL, Dong Y, Tan OL, Gardiner R, Samaratunga HM, Nicol DL, Clements JA.
Biol Chem. 2010 Apr;391(4):461-6. doi: 10.1515/BC.2010.043.
Similar articles
Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases.
Lawrence MG, Veveris-Lowe TL, Whitbread AK, Nicol DL, Clements JA.
Cells Tissues Organs. 2007;185(1-3):111-5. Review.
Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.
Veveris-Lowe TL, Kruger SJ, Walsh T, Gardiner RA, Clements JA.
Semin Thromb Hemost. 2007 Feb;33(1):87-99. Review.
The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition.
Whitbread AK, Veveris-Lowe TL, Lawrence MG, Nicol DL, Clements JA.
Biol Chem. 2006 Jun;387(6):707-14. Review.
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
Veveris-Lowe TL, Lawrence MG, Collard RL, Bui L, Herington AC, Nicol DL, Clements JA.
Endocr Relat Cancer. 2005 Sep;12(3):631-43.
Co-expression of GH and GHR isoforms in prostate cancer cell lines.
Chopin LK, Veveris-Lowe TL, Philipps AF, Herington AC.
Growth Horm IGF Res. 2002 Apr;12(2):126-36.
Filters: Manage Filters